CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Dogecoin Cash Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Dogecoin Cash Inc
355 W MESQUITE BLVD, C70
Phone: (323) 420-8683p:323 420-8683 MESQUITE, NV  89027  United States Ticker: DOGPDOGP
Business Summary
Dogecoin Cash, Inc. owns and operates PrestoDoctor, a telemedicine provider for medical cannabis. The Company holds the patented cannabis strain, Ecuadorian Sativa, also known as CTA, and a patented cannabis lozenge for the treatment of hypertension. It engages in cannabis product development and licensing, as well as focusing on blockchain innovation and developing blockchain-based infrastructure and digital asset initiatives. Its subsidiary, MEME Coins Inc., holds DOG tokens as its sole digital asset and is a platform focused on meme-based cryptocurrency innovation, token utility, and social crypto applications. PrestoCorp provides telemedicine online referral services for customers desiring medical marijuana cards in states where medical marijuana has been legalized. The Company focuses on cannabis telemedicine, developing and commercializing cannabis-based products, including CBD-infused wellness solutions, consumer goods, and pharmaceutical-grade formulations.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/202512/31/2024YesYes---

Industries
SIC Code Description
7200 Personal services
7375 Information retrieval services
2833 Medicinal chemicals and botanical products

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, President, Chief Executive Officer, Company Secretary DavidTobias 73 1/19/2025 7/12/2013
Treasurer, Director CatherineCarroll 83 1/30/2017 7/12/2013
Director Robert N.Tankson 38 1/31/2020 1/31/2020
Independent Director Trevor S.Reed 61 5/1/2016 1/4/2016

Business Names
Business Name
CBDS
DOGP
Eden Holdings LLC
7 additional Business Names available in full report.

General Information
Number of Employees: 1 (As of 12/31/2018)
Outstanding Shares: 143,903,923 (As of 3/31/2025)
Shareholders: 70
Stock Exchange: OTC
Federal Tax Id: 201898270


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, June 27, 2025